Get Live Data

Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video

Latest Share Chat

  2. Share Prices
  3. Alliance Pharma Share Price
  4. Alliance Pharma Share Regulatory News
  5. Director Share options

Pin to quick picksAlliance Pharma Regulatory News (APH)

Alliance Pharma Information

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.90
Bid: 41.60
Ask: 41.70
Change: 1.40 (3.46%)
Spread: 0.10 (0.24%)
Open: 40.00
High: 43.00
Low: 39.50
Prev. Close: 40.50
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share options

16 Apr 2009 10:48

RNS Number : 6736Q
Alliance Pharma PLC
16 April 2009
 



For Immediate Release

16 April 2009

ALLIANCE PHARMA PLC

("the Company")

Share Options

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that on 14 April 2009 it awarded the following options over ordinary shares of the Company to certain Directors.

Name

Position

Number of options awarded

Exercise price per share

Date of vesting

Percentage of issued ordinary share capital

Tony Booley

Sales & Marketing Director

110,000

7.75p

14 April 2012

0.07%

Richard Wright

Finance Director

113,000

7.75p

14 April 2012

0.07%

For further information: 

Alliance Pharma plc
+ 44 (0) 1249 466966
John Dawson, Chief Executive
 
Richard Wright, Finance Director
 

www.alliancepharma.co.uk
 
 
 
Buchanan Communications
+ 44 (0) 20 7466 5000
Mark Court / Rebecca Skye Dietrich / Stasa Filiplic
 
 
 
Numis Securities
+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Brent Nabbs
 
Corporate Broking: David Poutney
 

 

Notes to editors

About Alliance Pharma

Alliance Pharma, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The company has a strong track record of acquiring the rights to established niche brands and owns, or licences, the rights to 35 branded pharmaceutical products and continues to explore opportunities to expand the range.

Alliance Pharma's products are prescribed in the treatment of a wide range of conditions and include brands used in the treatment of dermatological conditions, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections. Alliance Pharma's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers which service both hospital and retail pharmacies with their prescription requirements.

Alliance Pharma joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUNSKRKSRSARR
567891011121314
Date   Source Headline
21st Jan 20115:49 pmRNSMajor Interest in Shares
12th Jan 20117:00 amRNSPre-close Trading Update
11th Jan 20111:43 pmRNSCULS Conversion
20th Dec 201010:11 amRNSCULS Conversion
3rd Dec 20104:45 pmRNSNotice of Major Interest in Shares
25th Nov 20102:06 pmRNSCULS Conversion
25th Nov 20107:00 amRNS£44 million Bank Facilities
15th Nov 20104:24 pmRNSMajor Interests in Shares
9th Nov 20108:44 amRNSCULS Conversion and Additional Listing
5th Nov 20102:19 pmRNSExercise of Options
11th Oct 20102:45 pmRNSDirector Shareholding
29th Sep 201012:26 pmRNSExercise of Options
20th Sep 201012:31 pmRNSExercise of Options
20th Sep 201012:09 pmRNSDirector Share Transfer
14th Sep 20102:18 pmRNSExercise of Options
13th Sep 201012:22 pmRNSExercise of Options
9th Sep 20103:54 pmRNSDirector Share Transfer
9th Sep 20108:55 amRNSMajor Interest in Shares
8th Sep 20107:01 amRNSCULS Conversion
8th Sep 20107:00 amRNSInterim Results
31st Aug 201012:37 pmRNSCULS Conversion
18th Aug 20105:06 pmRNSTR-1: Notification of major interests in shares
17th Aug 20107:00 amRNSNotice of Interim Results
30th Jul 20104:10 pmRNSMajor Interests in Shares
30th Jul 201011:32 amRNSMajor Interest in Shares
29th Jul 20103:02 pmRNSMajor Interests in Shares
22nd Jul 20104:44 pmRNSExercise of Options
15th Jul 20104:59 pmRNSMajor Interests in Shares
9th Jul 20103:20 pmRNSMajor Interest in Shares
7th Jul 20109:07 amRNSExercise of Options
6th Jul 201011:53 amRNSExercise of Options
6th Jul 20107:00 amRNSPre-Close Trading Update
5th Jul 201012:18 pmRNSMajor Interest in Shares
1st Jul 20104:26 pmRNSCULS Conversion
22nd Jun 201010:15 amRNSMajor Interest in Shares
22nd Jun 20107:00 amRNSDirector Shareholding
7th Jun 201011:49 amRNSCULS Conversion
27th May 20107:00 amRNSAGM Statement
20th May 201010:05 amRNSCULS Conversion
10th May 20103:35 pmRNSCULS Conversion and Additional Listing
7th May 20107:00 amRNSMajor Interest in Shares
4th May 201012:04 pmRNSExercise of Options
29th Apr 20102:55 pmRNSShare Options
27th Apr 20109:57 amRNSAnnual Report and AGM Notice
6th Apr 20107:00 amRNSDirector Shareholding
30th Mar 20102:15 pmRNSCULS Conversion
29th Mar 20102:06 pmRNSExercise of Options
26th Mar 20104:01 pmRNSShare Options
25th Mar 201010:37 amRNSDirector Shareholding
24th Mar 20107:00 amRNSPreliminary results
567891011121314

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.